Volume 65, Issue 1, Pages S2-S21 (October 2016)

Slides:



Advertisements
Similar presentations
Laurent Mailly, Mirjam B. Zeisel, Thomas F. Baumert 
Advertisements

Volume 50, Issue 3, Pages (March 2009)
Volume 63, Issue 1, Pages (July 2015)
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Volume 46, Issue 3, Pages (March 2007)
Volume 61, Issue 4, Pages (October 2014)
Pathogenesis and Treatment of Hepatitis E Virus Infection
Volume 19, Issue 6, Pages (June 2016)
Tissue culture and animal models for hepatitis C virus
Volume 44, Issue 2, Pages (February 2006)
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Volume 65, Issue 4, Pages (October 2016)
Replication of Hepatitis C Virus Genotype 3a in Cultured Cells
Volume 63, Issue 4, Pages (October 2015)
Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population  Y.-Q. Tong, B. Liu,
NS5A inhibitors in the treatment of hepatitis C
Pathogenesis and Treatment of Hepatitis E Virus Infection
Volume 141, Issue 3, Pages (September 2011)
Volume 141, Issue 3, Pages (September 2011)
Volume 146, Issue 3, Pages e4 (March 2014)
Volume 140, Issue 2, Pages e1 (February 2011)
Immigration and viral hepatitis
Volume 44, Issue 5, Pages (May 2006)
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert 
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Jean-Michel Pawlotsky, MD, PhD  Clinics in Liver Disease 
David G. Bowen, Christopher M. Walker  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention  Stanley M. Lemon, Jördis J. Ott, Pierre.
Hepatitis C Virus Replicons Volume 3 and 4
Hepatitis E: An emerging awareness of an old disease
Volume 133, Issue 5, Pages (November 2007)
Volume 140, Issue 3, Pages e12 (March 2011)
Yasuhiko Sugawara, Masatoshi Makuuchi 
Volume 136, Issue 4, Pages (April 2009)
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Hepatocyte-like cells differentiated from human induced pluripotent stem cells (iHLCs) are permissive to hepatitis C virus (HCV) infection: HCV study.
Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population  Y.-Q. Tong, B. Liu,
From non-A, non-B hepatitis to hepatitis C virus cure
Volume 44, Issue 2, Pages (February 2006)
RNAi – A powerful tool to unravel hepatitis C virus–host interactions within the infectious life cycle  Joachim Lupberger, Laurent Brino, Thomas F. Baumert 
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Tracking the naturally occurring mutations across the full-length genome of hepatitis B virus of genotype D in different phases of chronic e-antigen-negative.
Volume 142, Issue 6, Pages e3 (May 2012)
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
Occupational transmission of hepatitis C virus resulting from use of the same supermarket meat slicer  L. Bocket, S. Chevaliez, N. Talbodec, A. Sobaszek,
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
Induced pluripotent stem cells: A new era for hepatology
HCV epidemiology in high-risk groups and the risk of reinfection
Tracing the Evolution of Hepatitis C Virus in the United States, Japan, and Egypt By Using the Molecular Clock  Masashi Mizokami, Yasuhito Tanaka  Clinical.
Volume 49, Issue 6, Pages (December 2008)
Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response.
Volume 15, Issue 6, Pages (December 2001)
Prevalence and Treatment of Hepatitis C Virus Genotypes 4, 5, and 6
Volume 128, Issue 3, Pages (March 2005)
Immigration and viral hepatitis
Pathogenesis and Treatment of Hepatitis E Virus Infection
Volume 121, Issue 5, Pages (November 2001)
Amplification and pyrosequencing of near-full-length hepatitis C virus for typing and monitoring antiviral resistant strains  P. Trémeaux, A. Caporossi,
Volume 63, Issue 1, Pages (July 2015)
HCV animal models and liver disease
Chimeric mouse model of hepatitis B virus infection
Mirjam B. Zeisel, Marine Turek, Thomas F. Baumert 
Understanding How Hepatitis C Virus Builds Its Unctuous Home
Volume 15, Issue 6, Pages (December 2001)
Reversion of disease manifestations after HCV eradication
Volume 53, Issue 4, Pages (October 2010)
Presentation transcript:

Volume 65, Issue 1, Pages S2-S21 (October 2016) The history of hepatitis C virus (HCV): Basic research reveals unique features in phylogeny, evolution and the viral life cycle with new perspectives for epidemic control  Jens Bukh  Journal of Hepatology  Volume 65, Issue 1, Pages S2-S21 (October 2016) DOI: 10.1016/j.jhep.2016.07.035 Copyright © 2016 Terms and Conditions

Fig. 1 Classification of hepatitis C virus (HCV) into 7 major genotypes and a large number of subtypes. The tree is based on phylogenetic analysis of the open reading frame (nucleotide) sequences. The overall prevalence and distribution is indicated for each major genotype. In part adapted from Smith et al. [55]. Journal of Hepatology 2016 65, S2-S21DOI: (10.1016/j.jhep.2016.07.035) Copyright © 2016 Terms and Conditions

Fig. 2 The generation of infectious cDNA clones of HCV. The full-length consensus HCV sequence for selected HCV strains was engineered into plasmids. In the absence of cell culture systems, infectivity was demonstrated by inoculating in vitro generated RNA transcripts directly into the liver of chimpanzees. Such in vivo infectious cDNA clones have been developed for HCV strains of genotypes 1a, 1b, 2a, 3a and 4a. The resulting monoclonal HCV infection in chimpanzees did not differ significantly from the polyclonal infection observed in animals infected intravenously with wild-type virus; here is shown an example of the course of infection observed in a chimpanzee transfected with RNA transcripts from an infectious cDNA clone of HCV (pCV-H77C) from patient H. The chimpanzee developed acute hepatitis with elevated liver enzyme levels and necro-inflammatory changes in liver biopsies. Based on original findings by Kolykhalov et al. [83] and Yanagi et al. [84]. Journal of Hepatology 2016 65, S2-S21DOI: (10.1016/j.jhep.2016.07.035) Copyright © 2016 Terms and Conditions

Fig. 3 Principle of the generation of HCV replicons. Diagram showing the composition of a sub-genomic viral replicon sequence consisting of the 5′ UTR, NS3-NS5B and the 3′ UTR from strain Con1 (genotype 1b) in a selectable bicistronic construct. To demonstrate viral replication, RNA transcripts generated from this genome were transfected into human hepatoma derived cells and the cells with replicating RNA was selected following treatment with neomycin. Subsequent analysis demonstrated that their replication capacity was determined by adaptive mutations of the replicating HCV RNA and by increased host cell permissiveness. Based on findings by Lohmann et al. [99]. Journal of Hepatology 2016 65, S2-S21DOI: (10.1016/j.jhep.2016.07.035) Copyright © 2016 Terms and Conditions

Fig. 4 Replication enhancing adaptive mutations renders full-length HCV clone non-viable in vivo. The wild-type Con1 genome was viable in vivo, but did not replicate in cell culture. Contrarily, genomes with mutations that permitted replication in cell culture were non-viable in vivo. Based on findings by Bukh et al. [119]. Journal of Hepatology 2016 65, S2-S21DOI: (10.1016/j.jhep.2016.07.035) Copyright © 2016 Terms and Conditions

Fig. 5 Principle of the generation of infectious HCV in cell culture, and demonstration of in vivo infectivity. Diagram showing the composition of full-length JFH1 and J6/JFH1 genomes. To demonstrate infectivity RNA transcripts generated from these genomes were transfected into human hepatoma derived cells and collected supernatant viruses were used to infect naïve cells. The immuno-staining shown was performed with a mouse monoclonal NS5A antibody. When passaged viruses were transmitted to chimpanzees or SCID-uPA mice with a human liver graft (human liver chimeric mice), the animals developed a productive HCV infection. Compared to culture derived viruses, the in vivo derived viruses had a high specific infectivity (ratio of infectivity titer to RNA titer). In part adapted from Bukh and Purcell [135]. Journal of Hepatology 2016 65, S2-S21DOI: (10.1016/j.jhep.2016.07.035) Copyright © 2016 Terms and Conditions